Rabbit Polyclonal ACL6A antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human ACTL6A aa 200-250.
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS, 0.88% Sodium chloride
WB | IHC-P | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Tested |
Cynomolgus monkey | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/1000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cynomolgus monkey | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 20 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cynomolgus monkey | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/500.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cynomolgus monkey | Dilution info - | Notes - |
Select an associated product type
Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Required for maximal ATPase activity of SMARCA4/BRG1/BAF190A and for association of the SMARCA4/BRG1/BAF190A containing remodeling complex BAF with chromatin/nuclear matrix. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and is required for the proliferation of neural progenitors. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Putative core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair.
BAF53, BAF53A, INO80K, ACTL6A, Actin-like protein 6A, 53 kDa BRG1-associated factor A, Actin-related protein Baf53a, ArpNbeta, BRG1-associated factor 53A, INO80 complex subunit K
Rabbit Polyclonal ACL6A antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human ACTL6A aa 200-250.
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS, 0.88% Sodium chloride
ACTL6A also known as BAF53A or Arp4 is a member of the actin-related protein family with a molecular mass of approximately 53 kDa. This protein plays an important role in chromatin remodeling facilitating transcriptional regulation by altering nucleosome positioning. ACTL6A shows expression in various tissues with high levels found in neurons and certain cancer cell types. Its function depends on local cellular context which influences its involvement in specific gene expression profiles.
ACTL6A supports transcriptional regulation by integrating into the SWI/SNF chromatin-remodeling complex. This complex which includes other key proteins coordinates to reposition nucleosomes aiding transcription factors in accessing target DNA sequences. ACTL6A contributes to regulation of gene expression patterns that underline cell identity and differentiation reflecting its critical role in neuronal and cancer cell biology.
The SWI/SNF complex which includes ACTL6A integrates into pathways that control cell proliferation and differentiation. Specifically the Wnt signaling pathway uses ACTL6A to regulate gene expression necessary for proper cell function. Proteins like BRG1 and BRM serve as partners in this process helping to execute transcriptional activation. By participating in these pathways ACTL6A emphasizes its role in conserving cellular homeostasis.
ACTL6A exhibits associations with oncogenesis and neural disorders. Researchers observed its link to the development of glioblastoma where it influences tumor progression through interactions with other SWI/SNF members like SMARCA4. Additionally abnormalities in ACTL6A function relate to neurodevelopmental disorders emphasizing its importance in neuronal growth and differentiation. Its connection to these diseases highlights the potential of ACTL6A as a target for therapeutic interventions.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-ACTL6A antibody (ab189315) at 1/500 dilution
Lane 1: Jurkat cell extracts
Lane 2: COLO205 cell extracts
Lane 3: Cell extracts treated with synthesized peptide.
Predicted band size: 47 kDa
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human skin tissue, labeling ACTL6A with ab189315 at 20 μg/ml.
Immunofluorescent analysis of HUVEC cells labeling ACTL6A with ab189315 at 1/100 dilution. The picture on the right is treated with the synthesized peptide.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com